Latest On Albemarle Corporation (ALB):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2024-06-14 05:40 EST | Dividend | A dividend of $0.4 has been announced on May 7, 2024. It will be paid Jul 1, 2024 with an ex-dividend date of Jun 14, 2024. | Neutral |  |
| 2024-03-14 05:40 EST | Dividend | A dividend of $0.4 has been announced on Feb 22, 2024. It will be paid Apr 1, 2024 with an ex-dividend date of Mar 14, 2024. | Neutral | |
| 2023-12-14 04:40 EST | Dividend | A dividend of $0.4 has been announced on Oct 23, 2023. It will be paid Jan 2, 2024 with an ex-dividend date of Dec 14, 2023. | Neutral | |
| 2023-09-14 05:40 EST | Dividend | A dividend of $0.4 has been announced on Jul 18, 2023. It will be paid Oct 2, 2023 with an ex-dividend date of Sep 14, 2023. | Neutral | |
| 2023-06-15 05:40 EST | Dividend | A dividend of $0.4 has been announced on May 2, 2023. It will be paid Jul 3, 2023 with an ex-dividend date of Jun 15, 2023. | Neutral | |
About Albemarle Corporation (ALB):
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical indust read more...ries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was incorporated in 1993 and is headquartered in Charlotte, North Carolina.
General
- Name Albemarle Corporation
- Symbol ALB
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorBasic Materials
- IndustrySpecialty Chemicals
- Full Time Employees 5,900
- Last Split Factor2:1
- Last Split Date2007-03-02
- Fiscal Year EndDecember
- IPO Date1994-02-17
- Gic SectorMaterials
- Gic GroupMaterials
- Gic IndustryChemicals
- Gic SubIndustrySpecialty Chemicals
- Web URLhttp://www.albemarle.com
Valuation
- Trailing PE 43.33
- Forward PE 44.84
- Price/Sales (Trailing 12 Mt.) 5.32
- Price/Book (Most Recent Quarter) 4.26
- Enterprise Value Revenue 6.75
- Enterprise Value EBITDA 31.13
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $3.52
- Next Year EPS Estimate $5.02
- Next Quarter EPS Estimate $0.91
- Profit Margin 12%
- Operating Margin 18%
- Return on Assets 3%
- Return on Equity 10%
- Revenue 3.13 billion
- Earnings Per Share $3.52
- Revenue Per Share $29.41
- Gross Profit 995.55 million
- Quarterly Earnings Growth -11.4%
ESG Rating
Highlights
- Market Capitalization 17.79 billion
- EBITDA 781.82 million
- PE Ratio -19.14
- PEG Ratio 2.95
- Analyst Target Price $147.07
- Book Value Per Share $39.95
Share Statistics
- Shares Outstanding 116.63 million
- Shares Float 116.18 million
- % Held by Insiders 32%
- % Held by Institutions 89.72%
- Shares Short 2.88 million
- Shares Short Prior Month 3.4 million
- Short Ratio 1.16
- Short % of Float 3%
- Short % of Shares Outstanding 2%
Technicals
- Beta 1.58
- 52 Week High $187.87
- 52 Week Low $48.22
- 50 Day Moving Average 156.05
- 200 Day Moving Average 131
Dividends
- Forward Annual Dividend Rate $1.56
- Forward Annual Dividend Yield 1%
- Payout Ratio 38%
- Dividend Date 2021-04-01
- ExDividend Date 2021-03-11
- Dividend Per Share $1.54
- Dividend Yield 1.76%
Albemarle Corporation (ALB) Dividend Calendar:
Albemarle Corporation pays an annual dividend of $1.56 per share, with a dividend yield of 1.76%.
ALB's last dividend payment was made to shareholders on April 1, 2021.
Albemarle Corporation pays out 38% of its earnings out as a dividend.
Albemarle Corporation (ALB) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Albemarle Corporation (ALB) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Albemarle Corporation (ALB) Chart:
Albemarle Corporation (ALB) News:
Below you will find a list of latest news for Albemarle Corporation (ALB) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Albemarle Corporation (ALB) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest ALB Trades:
Albemarle Corporation (ALB) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-04 | 8-K (Current report) | |
| 2020-11-04 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-09-15 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-27 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-12 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-11 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-05 | 8-K (Current report) | |
| 2020-08-05 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-07-08 | SC 13G/A (Statement of acquisition of beneficial ownership by individuals) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
Albemarle Corporation (ALB) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Albemarle Corporation (ALB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 32%
Institutional Ownership: 8972%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-09-15 | LUTHER C IV KISSAM | Director | Sell | 59,000.00 | 100.03 | 5,901,770.00 | 184,065.00 | |
| 2020-09-15 | LUTHER C IV KISSAM | Director | Buy | 59,000.00 | 66.14 | 3,902,260.00 | 243,065.00 | |
| 2020-08-11 | LUTHER C IV KISSAM | Director | Sell | 389.00 | 92.00 | 35,788.00 | 187,065.00 | |
| 2020-08-11 | LUTHER C IV KISSAM | Director | Sell | 38,358.00 | 91.43 | 3,507,071.94 | 187,454.00 | |
| 2020-08-11 | LUTHER C IV KISSAM | Director | Sell | 111,254.00 | 90.46 | 10,064,036.84 | 225,812.00 | |
| 2020-08-09 | Netha N. Johnson | President, Bromine Specialties | Buy | 3,308.00 | 5,634.00 | | ||
| 2020-07-01 | J Kent Masters | Chairman, President & CEO | Sell | 354.00 | 16,700.00 | | ||
| 2020-07-01 | LUTHER C IV KISSAM | Director | Buy | 5,381.00 | 332,811.00 | | ||
| 2020-07-01 | LUTHER C IV KISSAM | Director | Buy | 6,551.00 | 336,956.00 | | ||
| 2020-07-01 | GLENDA J MINOR | Director | Buy | 1,725.00 | 3,375.00 | | ||
| 2020-07-01 | LUTHER C IV KISSAM | Director | Buy | 5,496.00 | 339,523.00 | | ||
| 2020-07-01 | Dean Seavers | Director | Buy | 1,725.00 | 5,175.00 | | ||
| 2020-07-01 | Diarmuid B. OConnell | Director | Buy | 1,725.00 | 5,175.00 | | ||
| 2020-07-01 | GERALD A STEINER | Director | Buy | 1,725.00 | 5,725.00 | | ||
| 2020-07-01 | LAURIE BRLAS | Director | Buy | 1,725.00 | 6,125.00 | | ||
| 2020-07-01 | Alejandro Daniel Wolff | Director | Buy | 1,725.00 | 8,256.00 | | ||
| 2020-05-12 | David Terrence Ryan | VP, Corp. Strategy & IR | Buy | 495.00 | 3,800.00 | | ||
| 2020-02-28 | KAREN G NARWOLD | EVP, Chief Admin Officer | Sell | 531.00 | 78.11 | 41,476.41 | 41,429.00 | |
| 2020-02-28 | Scott Tozier | EVP & CFO | Sell | 630.00 | 78.11 | 49,209.30 | 53,528.00 | |
| 2020-02-26 | Raphael Goszcz Crawford | President, Catalysts | Buy | 1,106.00 | 10,383.00 | |